Yutaka Furukawa

Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI

Hirotoshi Watanabe, Takenori Domei, Takeshi Morimoto et al. · JAMA · 2019 · 834 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

An HMG-CoA Reductase Inhibitor, Cerivastatin, Suppresses Growth of Macrophages Expressing Matrix Metalloproteinases and Tissue Factor In Vivo and In Vitro

Masanori Aikawa, Elena Rabkin, Seigo Sugiyama et al. · Circulation · 2001 · 591 citations · Full text

Medicine, Cardiology, Pharmacology +17

Cytokine Gene Expression After Myocardial Infarction in Rat Hearts

Koh Ono, Akira Matsumori, Tetsuo Shioi et al. · Circulation · 1998 · 417 citations · Full text

Life Sciences, Cardiology, Immunology +17

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Kausik K Ray, Helen M Colhoun, Michael Szarek et al. · The Lancet Diabetes & Endocrinology · 2019 · 328 citations · Full text

Medicine, Cardiology, Internal Medicine +15

Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome

Hirotoshi Watanabe, Takeshi Morimoto, Masahiro Natsuaki et al. · JAMA Cardiology · 2022 · 300 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17